Skeletal hormones and the C/EBP and Runx transcription factors: Interactions that integrate and redefine gene expression

Gene

Volumn 342, Issue 1, 2004, Pages 13-24

  Centrella, Michael ^a   Christakos, Sylvia ^a,b   McCarthy, Thomas L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

C EBP; Runx; Skeletal hormones

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIETHYLSTILBESTROL; ESTRADIOL; GLUCOCORTICOID; PARATHYROID HORMONE; PROSTAGLANDIN E2; SEX HORMONE; SOMATOMEDIN; STEROID RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN D;

BINDING SITE; BONE REMODELING; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; BONE DEVELOPMENT; CCAAT-ENHANCER-BINDING PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HORMONES; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS; PROTEIN BINDING; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; VITAMIN D;

EID: 7644220887     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2004.06.036     Document Type: Review

References (125)

1. J.D. Adachi, and A. Papaioannou Corticosteroid-induced osteoporosis: detection and management Drug Safety 24 2001 607 624
2. S. Advani, D. LaFrancis, E. Bogdanovic, P. Taxel, L.G. Raisz, and B.E. Kream Dexamethasone suppresses in vivo levels of bone collagen synthesis in neonatal mice Bone 20 1997 41 46
3. T. Alam, M.R. An, and J. Papaconstantinou Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response J. Biol. Chem. 267 1992 5021 5024
4. S.C. Bae, Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1 Oncogene 8 1993 809 814
5. A. Balogh, E. Kauf, R. Vollanth, G. Graser, G. Klinger, and M. Oettel Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) growth hormone (hGH) Contraception 62 2000 259 269
6. C. Banerjee, S.W. Hiebert, J.L. Stein, J.B. Lian, and G.S. Stein An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene Proc. Natl. Acad. Sci. U. S. A. 93 1996 4968 4973
7. C. Banerjee, L.R. McCabe, J.Y. Choi, S.W. Hiebert, J.L. Stein, G.S. Stein, and J.B. Lian Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex J. Cell. Biochem. 66 1997 1 8
8. H. Baumann, K.K. Morella, S.P. Campos, Z. Cao, and G.P. Jahreis Role of CAAT-enhancer binding protein isoforms in the cytokine regulation of acute-phase plasma protein genes J. Biol. Chem. 267 1992 19744 19751
9. T. Bellido, A.A. Ali, L.I. Plotkin, Q. Fu, I. Gubrij, P.K. Roberson, R.S. Weinstein, C.A. O'Brien, S.C. Manolagas, and R.L. Jilka Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism J. Biol. Chem. 278 2003 50259 50272
10. D.D. Bikle, T. Sakata, C. Leary, H. Elalieh, D. Ginzinger, C.J. Rosen, W. Beamer, S. Majumdar, and B.P. Halloran Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone J. Bone Miner. Res. 17 2002 1570 1578
11. J. Billiard, Y. Umayahara, K. Wiren, M. Centrella, T.L. McCarthy, and P. Rotwein Regulated nuclear-cytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts J. Biol. Chem. 276 2001 15354 15361
12. E. Canalis, T.L. McCarthy, and M. Centrella Differential effects of continuous and transient treatment with parathyroid hormone related peptide (PTHrp) on bone collagen synthesis Endocrinology 126 1990 1806 1812
13. M. Centrella, T.L. McCarthy, and E. Canalis Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone Mol. Cell. Biol. 11 1991 4490 4496
14. M. Centrella, V. Rosen, J.M. Wozney, S.R. Casinghino, and T.L. McCarthy Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures J. Cell. Biochem. 67 1997 528 540
15. M. Centrella, T.L. McCarthy, W.-Z. Chang, D.C. Labaree, and R.B. Hochberg Estren (4-Estren-3{alpha},17{beta}-diol) is a prohormone that regulates both androgenic and estrogenic transcriptional effects through the androgen receptor Mol. Endocrinol. 18 2004 1120 1130
16. D.J. Chang, C. Ji, K.K. Kim, S. Casinghino, T.L. McCarthy, and M. Centrella Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid J. Biol. Chem. 273 1998 4892 4896
17. D. Chikazu, X. Li, H. Kawaguchi, Y. Sakuma, O.S. Voznesensky, D.J. Adams, M. Xu, K. Hoshio, V. Katavic, H.R. Herschman, L.G. Raisz, and C.C. Pilbeam Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo J. Bone Miner. Res. 17 2002 1430 1440
18. Z.C. Dang, R.L. van Bezooijen, M. Karperien, S.E. Papapoulos, and C.W. Lowik Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis J. Bone Miner. Res. 17 2002 394 405
19. C. Desbois, B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. Goldstein, C. Gundberg, A. Bradley, G. Karsenty, and V. Geoffroy A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element Nature 382 1996 448 452
20. P. Dhawan, X. Peng, M. Centrella, T.L. McCarthy, and S. Christakos Evidence for functional cooperation between CCAAT/enhancer binding protein beta and the VDR/RXR complex in the regulation of 25-hydroxyvitamin D3 24-hydroxylase transcription J. Bone Miner. Res. 17 2002 S393
21. P. Dhawan, X. Peng, M. Huening, M. Centrella, T.L. McCarthy, and S. Christakos Evidence for a role of C/EBP beta in the cross talk between parathyroid hormone and 1,25(OH)2D3 that involves enhancement of protein kinase A mediated induction of vitamin D receptor transcription J. Bone Miner. Res. 18 2003 S30
22. T.L. Donahue, T.R. Haut, C.E. Yellowley, H.J. Donahue, and C.R. Jacobs Mechanosensitivity of bone cells to oscillating fluid flow induced shear stress may be modulated by chemotransport J. Biomech. 36 2003 1363 1371
23. H. Drissi, A. Pouliot, C. Koolloos, J.L. Stein, J.B. Lian, G.S. Stein, and A.J. van Wijnen 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter Exp. Cell Res. 274 2002 323 333
24. P. Ducy, R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation Cell 89 1997 747 754
25. M. Ernst, and G.A. Rodan Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control Mol. Endocrinol. 5 1991 1081 1089
26. M. Ernst, J.K. Heath, and G.A. Rodan Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones Endocrinology 125 1989 825 833
27. R.T. Franceschi, and G. Xiao Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways J. Cell. Biochem. 88 2003 446 454
28. R. Galien, H.F. Evans, and T. Garcia Involvement of CCAAT/enhancer- binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens Mol. Endocrinol. 10 1996 713 722
29. A.E. Grigoriadis, J.N. Heersche, and J.E. Aubin Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone J. Cell Biol. 106 1988 2139 2151
30. K. Gu, L. Zhang, T. Jin, and R.B. Rutherford Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7 Cells Tissues Organs 176 2004 28 40
31. S. Gutierrez, A. Javed, D.K. Tennant, M. van Rees, M. Montecino, G.S. Stein, J.L. Stein, and J.B. Lian CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression J. Biol. Chem. 277 2002 1316 1323
32. J.R. Harrison, P.L. Kelly, and C.C. Pilbeam Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin-1 in osteoblastic MC3T3-E1 cells J. Bone Miner. Res. 15 2000 1138 1146
33. M. Homme, C.P. Schmitt, R. Himmele, G.F. Hoffmann, O. Mehls, and F. Schaefer Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells Endocrinology 144 2003 2496 2504
34. M. Huening, G. Yehia, C.A. Molina, and S. Christakos Evidence for a regulatory role of inducible cAMP early repressor in protein kinase A-mediated enhancement of vitamin D receptor expression and modulation of hormone action Mol. Endocrinol. 16 2002 2052 2064
35. Y. Ito Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF Genes Cells 4 1999 685 696
36. A. Javed, S. Gutierrez, M. Montecino, A.J. van Wijnen, J.L. Stein, G.S. Stein, and J.B. Lian Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization Mol. Cell. Biol. 19 1999 7491 7500
37. M.J. Jeon, J.A. Kim, S.H. Kwon, S.W. Kim, K.S. Park, S.W. Park, S.Y. Kim, and C.S. Shin Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts J. Biol. Chem. 278 2003 23270 23277
38. C. Ji, S. Casinghino, T.L. McCarthy, and M. Centrella Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor J. Biol. Chem. 272 1997 21260 21267
39. C. Ji, S. Casinghino, D.J. Chang, Y. Chen, A. Javed, Y. Ito, S.W. Hiebert, J.B. Lian, G.S. Stein, T.L. McCarthy, and M. Centrella CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation J. Cell. Biochem. 69 1998 353 363
40. C. Ji, W. Chang, M. Centrella, and T.L. McCarthy Activation domains of CCAAT enhancer binding protein delta: regions required for native activity and prostaglandin E2-dependent transactivation of insulin-like growth factor I gene expression in rat osteoblasts Mol. Endocrinol. 17 2003 1834 1843
41. D.N. Kalu The ovariectomized rat model of postmenopausal bone loss Bone Miner. 15 1991 175 191
42. D.N. Kalu, B.H. Arjmandi, C.C. Liu, M.A. Salih, and R.S. Birnbaum Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 Bone Miner. 25 1994 135 148
43. G. Karsenty Role of Cbfa1 in osteoblast differentiation and function Semin. Cell Dev. Biol. 11 2000 343 346
44. M. Kassem, S.A. Harris, T.C. Spelsberg, and B.L. Riggs Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors J. Bone Miner. Res. 11 1996 193 199
45. M. Kassem, R. Okazaki, S.A. Harris, T.C. Spelsberg, C.A. Conover, and B.L. Riggs Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor Calcif. Tissue Int. 62 1998 60 66
46. E. Khan, and Y. Abu-Amer Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts J. Lab. Clin. Med. 142 2003 29 34
47. S. Kimoto, S.L. Cheng, S.F. Zhang, and L.V. Avioli The effect of glucocorticoid on the synthesis of biglycan and decorin in human osteoblasts and bone marrow stromal cells Endocrinology 135 1994 2423 2431
48. T. Komori A fundamental transcription factor for bone and cartilage Biochem. Biophys. Res. Commun. 276 2000 813 816
49. T. Komori, H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 89 1997 755 764
50. S. Kousteni, J.R. Chen, T. Bellido, L. Han, A.A. Ali, C.A. O'Brien, L. Plotkin, Q. Fu, A.T. Mancino, Y. Wen, A.M. Vertino, C.C. Powers, S.A. Stewart, R. Ebert, A.M. Parfitt, R.S. Weinstein, R.L. Jilka, and S.C. Manolagas Reversal of bone loss in mice by nongenotropic signaling of sex steroids Science 298 2002 843 846
51. S. Kousteni, L. Han, J.R. Chen, M. Almeida, L.I. Plotkin, T. Bellido, and S.C. Manolagas Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids J. Clin. Invest. 111 2003 1651 1664
52. A.V. Krishnan, S.D. Cramer, F.R. Bringhurst, and D. Feldman Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways Endocrinology 136 1995 705 712
53. V. Krishnan, T.L. Moore, Y.L. Ma, L.M. Helvering, C.A. Frolik, K.M. Valasek, P. Ducy, and A.G. Geiser Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling Mol. Endocrinol. 17 2003 423 435
54. M. Kundu, A. Javed, J.P. Jeon, A. Horner, L. Shum, M. Eckhaus, M. Muenke, J.B. Lian, Y. Yang, G.H. Nuckolls, G.S. Stein, and P.P. Liu Cbfbeta interacts with Runx2 and has a critical role in bone development Nat. Genet. 32 2002 639 644
55. J. Lekstrom-Himes, and K.G. Xanthopoulos Biological role of the CCAAT/enhancer-binding protein family of transcription factors J. Biol. Chem. 273 1998 28545 28548
56. J.B. Lian, G.S. Stein, J.L. Stein, A. van Wijnen, L. McCabe, C. Banerjee, and H. Hoffmann The osteocalcin gene promoter provides a molecular blueprint for regulatory mechanisms controlling bone tissue formation: role of transcription factors involved in development Connect. Tissue Res. 35 1996 15 21
57. J.B. Lian, J.L. Stein, G.S. Stein, A.J. van Wijnen, M. Montecino, A. Javed, S. Gutierrez, J. Shen, S.K. Zaidi, and H. Drissi Runx2/Cbfa1 functions: diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions Connect. Tissue Res. 1 Suppl. 1 2003 141 148
58. B.P. Lukert, and L.G. Raisz Glucocorticoid-induced osteoporosis Rheum. Dis. Clin. North Am. 20 1994 629 650
59. C.A. Luppen, N. Leclerc, T. Noh, A. Barski, A. Khokhar, A.L. Boskey, E. Smith, and B. Frenkel Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2 J. Biol. Chem. 278 2003 44995 45003
60. T.L. McCarthy, and M. Centrella Local IGF-I expression and bone formation Growth Hormone IGF Res. 11 2001 213 219
61. T.L. McCarthy, M. Centrella, and E. Canalis Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone Endocrinology 124 1989 1247 1253
62. T.L. McCarthy, M. Centrella, and E. Canalis Cortisol inhibits the synthesis of insulin-like growth factor I in bone cell cultures Endocrinology 126 1990 1569 1575
63. T.L. McCarthy, M. Centrella, and E. Canalis Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures J. Biol. Chem. 265 1990 15353 15356
64. T.L. McCarthy, M. Centrella, L.G. Raisz, and E. Canalis Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone Endocrinology 128 1991 2895 2900
65. T.L. McCarthy, M.J. Thomas, M. Centrella, and P. Rotwein Regulation of insulin-like growth factor I transcription by cyclic adenosine 3',5'-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: protein kinase A-dependent control without a consensus AMP response element Endocrinology 136 1995 3901 3908
66. T.L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, P. Rotwein, and M. Centrella 17beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures J. Biol. Chem. 272 1997 18132 18139
67. T.L. McCarthy, C. Ji, Y. Chen, K. Kim, and M. Centrella Time-and dose-related interactions between glucocorticoid and cyclic adenosine 3′,5′-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts Endocrinology 141 2000 127 137
68. T.L. McCarthy, C. Ji, Y. Chen, K.K. Kim, M. Imagawa, Y. Ito, and M. Centrella Runt domain factor (Runx)-dependent effects on CCAAT/enhancer-binding protein delta expression and activity in osteoblasts J. Biol. Chem. 275 2000 21746 21753
69. T.L. McCarthy, W.-Z. Chang, Y. Liu, and M. Centrella Runx2 integrates estrogen activity in osteoblasts J. Biol. Chem. 278 2003 43121 43129
70. S. Mink, U. Kerber, and K.H. Klempnauer Interaction of C/EBPbeta and v-Myb is required for synergistic activation of the mim-1 gene Mol. Cell. Biol. 16 1996 1316 1325
71. S. Mink, B. Haenig, and K.H. Klempnauer Interaction and functional collaboration of p300 and C/EBPβ Mol. Cell. Biol. 17 1997 6609 6617
72. N. Miyakoshi, Y. Kasukawa, T.A. Linkhart, D.J. Baylink, and S. Mohan Evidence that anabolic effects of PTH on bone require IGF-I in growing mice Endocrinology 142 2001 4349 4356
73. K. Miyamoto, R.A. Kesterson, H. Yamamoto, Y. Taketani, E. Nishiwaki, S. Tatsumi, Y. Inoue, K. Morita, E. Takeda, and J.W. Pike Structural organization of the human vitamin D receptor chromosomal gene and its promoter Mol. Endocrinol. 11 1997 1165 1179
74. K. Mori, A. Shioi, S. Jono, Y. Nishizawa, and H. Morii Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 19 1999 2112 2118
75. S. Moverare, J. Dahllund, N. Andersson, U. Islander, H. Carlsten, J.A. Gustafsson, S. Nilsson, and C. Ohlsson Estren is a selective estrogen receptor modulator with transcriptional activity Mol. Pharmacol. 64 2003 1428 1433
76. L.J. Murphy, and H. Friesen Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat Endocrinology 122 1988 325 332
77. Y.-M. Ning, and D.M. Robins AML3/CBFα1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene J. Biol. Chem. 274 1999 30624 30630
78. C.A. O'Brien, D. Jia, L.I. Plotkin, T. Bellido, C.C. Powers, S.A. Stewart, S.C. Manolagas, and R.S. Weinstein Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength Endocrinology 145 2004 1835 1841
79. Y. Ogata, M. Yamauchi, R.H. Kim, J.J. Li, L.P. Freedman, and J. Sodek Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter Eur. J. Biochem. 230 1995 183 192
80. R. Paredes, J. Gutierrez, S. Gutierrez, L. Allison, M. Puchi, M. Imschenetzky, A. van Wijnen, J. Lian, G. Stein, J. Stein, and M. Montecino Interaction of the 1alpha,25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling Biochem. J. 363 2002 667 676
81. G. Passeri, R.L. Jilka, and S.C. Manolagas Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal J. Clin. Invest. 93 1994 1516 1524
82. A. Plant, and J.H. Tobias Characterisation of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice J. Cell. Biochem. 82 2001 683 691
83. A. Plant, A. Samuels, M.J. Perry, S. Colley, R. Gibson, and J.H. Tobias Estrogen-induced osteogenesis in mice is associated with the appearance of Cbfa1-expressing bone marrow cells J. Cell. Biochem. 84 2002 285 294
84. V. Poli, R. Balena, E. Fattori, A. Markatos, M. Yamamoto, H. Tanaka, G. Ciliberto, G.A. Rodan, and F. Costantini Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion EMBO J. 13 1994 1189 1196
85. D. Porte, J. Tuckermann, M. Becker, B. Baumann, S. Teurich, T. Higgins, M.J. Owen, M. Schorpp-Kistner, and P. Angel Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone Oncogene 18 1999 667 678
86. M. Prince, C. Banerjee, A. Javed, J. Green, J.B. Lian, G.S. Stein, P.V. Bodine, and B.S. Komm Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts J. Cell. Biochem. 80 2001 424 440
87. L.G. Raisz, and Y.S. Chyun Glucocorticoids and bone matrix formation Adv. Exp. Med. Biol. 171 1984 131 136
88. D.P. Ramji, and P. Foka CCAAT/enhancer-binding proteins: structure, function and regulation Biochem. J. 365 2002 561 575
89. A. Ray, K.E. Prefontaine, and P. Ray Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor J. Biol. Chem. 269 1994 12940 12946
90. P. Ray, S.K. Ghosh, D.H. Zhang, and A. Ray Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor FEBS Lett. 409 1997 79 85
91. C.J. Rosen The cellular and clinical parameters of anabolic therapy for osteoporosis Crit. Rev. Eukaryot. Gene Expr. 13 2003 25 38
92. S.K. Roy Regulation of transforming growth factor-b-receptor type I and type II messenger ribonucleic acid expression in the hamster ovary by gonadotropins and steroid hormones Biol. Reprod. 62 2000 1858 1865
93. K. Sasaki, H. Yagi, R.T. Bronson, K. Tominaga, T. Matsunashi, K. Deguchi, Y. Tani, T. Kishimoto, and T. Komori Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta Proc. Natl. Acad.Sci. U. S. A. 93 1996 12359 12363
94. N. Selvamurugan, M.R. Pulumati, D.R. Tyson, and N.C. Partridge Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1 J. Biol. Chem. 275 2000 5037 5042
95. L.B. Sher, H.W. Woitge, D.J. Adams, G.A. Gronowicz, Z. Krozowski, J.R. Harrison, and B.E. Kream Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone Endocrinology 145 2004 922 929
96. D.A. Shewmon, J.L. Stock, C.J. Rosen, K.M. Heiniluoma, M.M. Hogue, A. Morrison, E.M. Doyle, T. Ukena, V. Weale, and S. Baker Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women Arterioscler. Thromb. 14 1994 1586 1593
97. J. Sierra, A. Villagra, R. Paredes, F. Cruzat, S. Gutierrez, A. Javed, G. Arriagada, J. Olate, M. Imschenetzky, A.J. van Wijnen, J.B. Lian, G.S. Stein, J.L. Stein, and M. Montecino Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity Mol. Cell.Biol. 23 2003 3339 3351
98. N.A. Sims, P. Clement-Lacroix, F. Da Ponte, Y. Bouali, N. Binart, R. Moriggl, V. Goffin, K. Coschigano, M. Gaillard-Kelly, J. Kopchick, R. Baron, and P.A. Kelly Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5 J. Clin. Invest. 106 2000 1095 1103
99. R. St-Arnaud, A. Arabian, R. Travers, F. Barletta, M. Raval-Pandya, K. Chapin, J. Depovere, C. Mathieu, S. Christakos, M.B. Demay, and F.H. Glorieux Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase- ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D Endocrinology 141 2000 2658 2666
100. B. Stein, and M.X. Yang Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta Mol. Cell.Biol. 15 1995 4971 4979
101. J.J. Stepan, J. Pospichal, J. Presl, and V. Pacovsky Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women Bone 8 1987 279 284
102. T. Tanaka, M. Kurokawa, K. Ueki, K. Tanaka, Y. Imai, K. Mitani, K. Okazaki, N. Sagata, Y. Yazaki, Y. Shibata, T. Kadowaki, and H. Hirai The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability Mol..Cell. Biol. 16 1996 3967 3979
103. A. Taranta, M. Brama, A. Teti, V. De luca, R. Scandurra, G. Spera, D. Agnusdei, J.D. Termine, and S. Migliaccio The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro Bone 30 2002 368 376
104. M.J. Thomas, Y. Umayahara, H. Shu, M. Centrella, P. Rotwein, and T.L. McCarthy Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts J. Biol. Chem. 271 1996 21835 21841
105. Y. Tintut, F. Parhami, V. Le, G. Karsenty, and L.L. Demer Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation J. Biol. Chem. 274 1999 28875 28879
106. L. Tou, N. Quibria, and J.M. Alexander Regulation of human cbfa1 gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs) Mol. Cell. Endocrinol. 183 2001 71 79
107. Tsuji, K., Noda, M., 2000. Identification and expression of a novel 3′-exon of mouse Runx1/Pebp2alphaB/Cbfa2/AML1 gene.
108. K. Turksen, and J.E. Aubin Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells J. Cell Biol. 114 1991 373 384
109. R.T. Turner, P. Backup, P.J. Sherman, E. Hill, G.L. Evans, and T.C. Spelsberg Mechanism of action of estrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity Endocrinology 131 1992 883 889
110. R.T. Turner, G.L. Evans, and G.K. Wakley Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption J. Bone Miner. Res. 8 1993 359 366
111. R.T. Turner, B.L. Riggs, and T.C. Spelsberg Skeletal effects of estrogen Endocr. Rev. 15 1994 275 300
112. Y. Umayahara, C. Ji, M. Centrella, P. Rotwein, and T.L. McCarthy CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone J. Biol. Chem. 272 1997 31793 31800
113. R.M. Umek, A.D. Friedman, and S.L. McKnight CCAAT-enhancer binding protein: a component of a differentiation switch Science 251 1991 288 292
114. J.L. Van den Brande A personal view on the early history of the insulin-like growth factors Horm. Res. 3 1999 149 175
115. V. Viereck, H. Siggelkow, S. Tauber, D. Raddatz, N. Schutze, and M. Hufner Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts J. Cell. Biochem. 86 2002 348 356
116. A. Villagra, J. Gutierrez, R. Paredes, J. Sierra, M. Puchi, M. Imschenetzky, A.J. van Wijnen, J. Lian, G. Stein, J. Stein, and M. Montecino Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts J. Cell. Biochem. 85 2002 112 122
117. F.S. Wang, C.J. Wang, S.M. Sheen-Chen, Y.R. Kuo, R.F. Chen, and K.D. Yang Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors J. Biol. Chem. 277 2002 10931 10937
118. H.J. Wee, G. Huang, K. Shigesada, and Y. Ito Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms EMBO Rep. 3 2002 967 974
119. J.J. Westendorf, C.M. Yamamoto, N. Lenny, J.R. Downing, M.E. Selsted, and S.W. Hiebert The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation Mol. Cell. Biol. 18 1998 322 333
120. M.E. Wilson Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I J. Clin. Endocrinol. Metab. 83 1998 2018 2028
121. H.W. Woitge, and B.E. Kream Calvariae from fetal mice with a disrupted Igf1 gene have reduced rates of collagen synthesis but maintain responsiveness to glucocorticoids J. Bone Miner. Res. 15 2000 1956 1964
122. S.L. Wyszomierski, and J.M. Rosen Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer- binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor Mol. Endocrinol. 15 2001 228 240
123. S. Yakar, J.L. Liu, B. Stannard, A. Butler, D. Accili, B. Sauer, and D. LeRoith Normal growth and development in the absence of hepatic insulin-like growth factor I Proc. Natl. Acad. Sci. U. S. A. 96 1999 7324 7329
124. S. Yakar, C.J. Rosen, W.G. Beamer, C.L. Ackert-Bicknell, Y. Wu, J.L. Liu, G.T. Ooi, J. Setser, J. Frystyk, Y.R. Boisclair, and D. LeRoith Circulating levels of IGF-1 directly regulate bone growth and density J. Clin. Invest. 110 2002 771 781
125. D.E. Zhang, C.J. Hetherington, S. Meyers, K.L. Rhoades, C.J. Larson, H.M. Chen, S.W. Hiebert, and D.G. Tenen CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter Mol. Cell. Biol. 16 1996 1231 1240